Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 7870189, 11 pages
http://dx.doi.org/10.1155/2016/7870189
Research Article

Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPAR and L-FABP Expressions in High-Fat-Fed Rats

1Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, Hong Kong
2Guangzhou University of Chinese Medicine, Guangzhou 510000, Hong Kong
3State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Shenzhen 518057, Hong Kong
4Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong

Received 30 June 2016; Revised 10 September 2016; Accepted 29 September 2016

Academic Editor: Srinivas Nammi

Copyright © 2016 Yu-feng Xing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. M. W. de Alwis and C. P. Day, “Non-alcoholic fatty liver disease: the mist gradually clears,” Journal of Hepatology, vol. 48, no. 1, pp. S104–S112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. B. W. Smith and L. A. Adams, “Non-alcoholic fatty liver disease,” Critical Reviews in Clinical Laboratory Sciences, vol. 48, no. 3, pp. 97–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Paschos and K. Paletas, “Non alcoholic fatty liver disease and metabolic syndrome,” Hippokratia, vol. 13, no. 1, pp. 9–19, 2009. View at Google Scholar · View at Scopus
  4. E. M. Brunt, “Nonalcoholic steatohepatitis: definition and pathology,” Seminars in Liver Disease, vol. 21, no. 1, pp. 3–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. M. Anstee and C. P. Day, “A lipid to treat non-alcoholic fatty liver disease—the dawn of ‘lipo-rehabilitation’?” Journal of Hepatology, vol. 56, no. 4, pp. 987–989, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies,” The Lancet, vol. 371, no. 9612, pp. 569–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Greenfield, O. Cheung, and A. J. Sanyal, “Recent advances in nonalcholic fatty liver disease,” Current Opinion in Gastroenterology, vol. 24, no. 3, pp. 320–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Xing and G.-D. Tong, “Experiences of professor Tong Guang-dong in treating nonalcoholic fatty liver disease,” Journal of Liaoning University of TCM, vol. 14, no. 8, pp. 178–179, 2012. View at Google Scholar
  9. F.-F. Zhai, H. Sun, X.-X. Su et al., “Clinical efficacy of Shugan Xiaozhi granules in treatment of nonalcoholic steatohepatitis,” Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, vol. 24, no. 2, pp. 78–82, 2014. View at Google Scholar
  10. S.-L. Li, J.-Z. Song, F. F. K. Choi et al., “Chemical profiling of Radix Paeoniae evaluated by ultra-performance liquid chromatography/photo-diode-array/quadrupole time-of-flight mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 49, no. 2, pp. 253–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Zhao, Y. S. Chang, and P. Chen, “Differentiation of Aurantii Fructus Immaturus from Poniciri Trifoliatae Fructus Immaturus using flow-injection mass spectrometric (FIMS) metabolic fingerprinting method combined with chemometrics,” Journal of Pharmaceutical and Biomedical Analysis, vol. 107, pp. 251–257, 2015. View at Publisher · View at Google Scholar
  12. L. Wang, S. Liu, X. Zhang, J. Xing, Z. Liu, and F. Song, “A strategy for identification and structural characterization of compounds from Gardenia jasminoides by integrating macroporous resin column chromatography and liquid chromatography-tandem mass spectrometry combined with ion-mobility spectrometry,” Journal of Chromatography A, vol. 1452, pp. 47–57, 2016. View at Publisher · View at Google Scholar
  13. Y. Yan, C.-Z. Chai, D.-W. Wang, X.-Y. Yue, D.-N. Zhu, and B.-Y. Yu, “HPLC-DAD-Q-TOF-MS/MS analysis and HPLC quantitation of chemical constituents in traditional Chinese medicinal formula Ge-Gen Decoction,” Journal of Pharmaceutical and Biomedical Analysis, vol. 80, pp. 192–202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Li, S. Jin, C. Song et al., “The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis rhizoma on high-fat diet induced hyperlipidemia mice,” Journal of Ethnopharmacology, vol. 177, pp. 10–18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Liang, K. Oh, Y. Wang, T. Yi, H. Chen, and Z. Zhao, “Cell type-specific qualitative and quantitative analysis of saikosaponins in three Bupleurum species using laser microdissection and liquid chromatography-quadrupole/time of flight-mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 97, pp. 157–165, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Xu, C.-O. Chan, C.-C. Lau, Z. Yu, D. K. W. Mok, and S. Chen, “Simultaneous determination of eight anthraquinones in Semen Cassiae by HPLC-DAD,” Phytochemical Analysis, vol. 23, no. 2, pp. 110–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Liu, Y. Guo, J. Zhang et al., “Systematic chemical analysis of flavonoids in the Nelumbinis stamen,” Phytomedicine, vol. 21, no. 13, pp. 1753–1758, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Wang, H. Dong, R. Yan et al., “Comparative study of lanostane-type triterpene acids in different parts of Poria cocos (Schw.) Wolf by UHPLC-Fourier transform MS and UHPLC-triple quadruple MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 102, pp. 203–214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. H. J. Renaud, J. Y. Cui, H. Lu, and C. D. Klaassen, “Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis,” PLoS ONE, vol. 9, no. 2, Article ID e88584, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two ‘Hits’?” Gastroenterology, vol. 114, no. 4, pp. 842–845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Liu, C. Gao, P. Yao, and Z. Gong, “Quercetin alleviates high-fat diet-induced oxidized low-density lipoprotein accumulation in the liver: implication for autophagy regulation,” BioMed Research International, vol. 2015, Article ID 607531, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Liu, L. Xu, L. Yin et al., “Potent effects of dioscin against obesity in mice,” Scientific Reports, vol. 5, article 7973, 2015. View at Publisher · View at Google Scholar
  23. A. Tailleux, K. Wouters, and B. Staels, “Roles of PPARs in NAFLD: potential therapeutic targets,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1821, no. 5, pp. 809–818, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Poirier, I. Niot, M.-C. Monnot et al., “Differential involvement of peroxisome-proliferator-activated receptors α and δ in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine,” Biochemical Journal, vol. 355, no. 2, pp. 481–488, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Schoonjans, J. Peinado-Onsurbe, A.-M. Lefebvre et al., “PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene,” The EMBO Journal, vol. 15, no. 19, pp. 5336–5348, 1996. View at Google Scholar · View at Scopus
  26. B. Staels, A. Rubenstrunk, B. Noel et al., “Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis,” Hepatology, vol. 58, no. 6, pp. 1941–1952, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. M. Anstee, A. K. Daly, and C. P. Day, “Genetic modifiers of non-alcoholic fatty liver disease progression,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1812, no. 11, pp. 1557–1566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Binas and E. Erol, “FABPs as determinants of myocellular and hepatic fuel metabolism,” Molecular and Cellular Biochemistry, vol. 299, no. 1-2, pp. 75–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T.-G. Cai and Y. Cai, “Triterpenes from the fungus poria cocos and their inhibitory activity on nitric oxide production in mouse macrophages via blockade of activating protein-1 pathway,” Chemistry and Biodiversity, vol. 8, no. 11, pp. 2135–2143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Wei, J. Wang, M. Shi, W. Liu, Z. Yang, and Y. Fu, “Saikosaponin a inhibits LPS-induced inflammatory response by inducing liver X receptor alpha activation in primary mouse macrophages,” Oncotarget, vol. 7, no. 31, pp. 48995–49007, 2016. View at Publisher · View at Google Scholar
  31. G. Kang and D. Kim, “Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance,” Journal of Ethnopharmacology, vol. 189, pp. 175–185, 2016. View at Publisher · View at Google Scholar
  32. W.-G. Gong, J.-L. Lin, Q.-X. Niu et al., “Paeoniflorin diminishes ConA-induced IL-8 production in primary human hepatic sinusoidal endothelial cells in the involvement of ERK1/2 and Akt phosphorylation,” International Journal of Biochemistry and Cell Biology, vol. 62, pp. 93–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. D. S. Dong, L. Xu, L. Yin, Y. Qi, and J. Peng, “Naringin prevents carbon tetrachloride-induced acute liver injury in mice,” Journal of Functional Foods, vol. 12, pp. 179–191, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Tan, A. Liu, M. Luo et al., “Geniposide inhibits α-naphthylisothiocyanate-induced intrahepatic cholestasis: the downregulation of STAT3 and NFκB signaling plays an important role,” The American Journal of Chinese Medicine, vol. 44, no. 4, pp. 721–736, 2016. View at Publisher · View at Google Scholar